Trump Requests 17 Pharmaceutical Companies to Lower Costs | WSJ

Drug Pricing Discrepancy - Brand-name drug prices in the US are more than three times higher than in other developed nations [1][2] - The administration aims to end this burden on American families [2] Proposed Solutions and Demands - The administration rejects proposals that shift blame and request billions of dollars in handouts to the industry [3] - The administration demands immediate relief from inflated drug prices and an end to the free ride on American innovation [3] - Drug manufacturers are called upon to extend most favored nation pricing to Medicaid [4] - Drug manufacturers are called upon to guarantee most favored nation pricing for newly launched drugs [4] - Drug manufacturers are called upon to return increased revenues abroad to American patients and taxpayers [4] - Drug manufacturers are called upon to provide for direct purchasing at most favored nation pricing [4] Potential Actions - The administration will deploy every tool to protect American families from abusive drug pricing practices if manufacturers refuse to comply [4]